Method for Efficient Transduction of Cancer Stem Cells.

Area of Science:

• Molecular Biology
• Virology
• Cancer Research

Background:

• Ectopic gene expression and gene silencing are crucial for studying molecular pathways.
• Lentivirus-based systems offer high infection rates, beneficial for cells with low transfection efficiency, such as glioblastoma cancer stem cells (CSCs).
• Existing methods face challenges, including the need to eliminate fetal bovine serum (FBS), which can induce differentiation.

Purpose of the Study:

• To develop a lentivirus production system that functions effectively in serum-free media suitable for CSCs.
• To overcome technical limitations hindering the use of lentivirus for gene manipulation in CSCs.
• To provide protocols for generating and utilizing this system for glioblastoma research.

Main Methods:

• Generation of a 293T cell subline (CSC293Ts) capable of viral production in CSC media.
• Detailed protocols for CSC293T generation and lentivirus production.
• Infection of glioblastoma cells using lentivirus produced in serum-free conditions.

Main Results:

• CSC293Ts efficiently produce lentivirus in serum-free media.
• Achieved infection rates exceeding 80% in glioblastoma cells without the need for virus concentration.
• Demonstrated the utility of the system in a glioblastoma model.

Conclusions:

• The CSC293T cell line and associated protocols facilitate high-efficiency lentiviral gene transfer in CSCs using serum-free conditions.
• This system simplifies experimental design and broadens the applicability of lentivirus technology for CSC research.
• The provided protocols are adaptable for various cell types, offering wide utility.